...
首页> 外文期刊>Pediatric Research >Efficacy of Dietary Arachidonic Acid Provided as Triglyceride or Phospholipid as Substrates for Brain Arachidonic Acid Accretion in Baboon Neonates
【24h】

Efficacy of Dietary Arachidonic Acid Provided as Triglyceride or Phospholipid as Substrates for Brain Arachidonic Acid Accretion in Baboon Neonates

机译:饮食性花生四烯酸(以甘油三酸酯或磷脂作为底物)对狒狒新生儿脑内花生四烯酸的吸收的功效

获取原文
           

摘要

Arachidonic acid (AA) is a long-chain polyunsaturate (LCP) present in human breast milk as both triglyceride (TG) and as phospholipid (PL). There has been little attention to the metabolic consequences of lipid form of AA in infant formulas. Our objective was to investigate the efficacy of dietary TG and PL as carriers of AA for accretion in the brain and associated organs of term baboon neonates consuming a formula with LCP composition typical of human milk. TG and phosphatidylcholine (PC) with [U-13C]-AA in the sn-2 position and with unlabeled 16:0 in the remaining positions (TG-AA* or PL-AA*, respectively) were used as tracers to study the tissue AA* incorporation. Baboon neonates received a single oral dose of either TG-AA* (n = 3) or PL-AA* (n = 4) at 18–19 d of life. Tissues were obtained 10 d later (28–29 d of life) and isotopic enrichment was measured. In the brain, 4.5% of the PL-AA* dose and 2.1% of the TG-AA* dose were recovered as brain AA*, respectively, indicating that PL was about 2.1-fold more effective than TG as a substrate for brain AA accretion. Preferential incorporation of PL-derived AA* over TG source of AA* was also observed in the liver, lung, plasma, and erythrocytes. Because of the quantitative predominance of TG-AA in formula, total brain AA accretion, expressed as absolute weight, was 5.0-fold greater from TG-AA than from PL-AA. We estimate that about half of postnatal brain AA accretion is derived from dietary preformed AA in term baboon neonates consuming a formula with lipid composition similar to that of human milk.Abbreviations: AA, arachidonic acid; AA*, [13C] arachidonic acid; DHA, docosahexaenoic acid; LA, linoleic acid; TG, triglyceride; PL, phospholipid; PC, phosphatidylcholine; TG-AA*, triglyceride containing [13C] arachidonic acid in the sn-2 position; PL-AA*, phosphatidylcholine containing [13C] arachidonic acid in the sn-2 position; TG-AA, dietary arachidonic acid provided as triglyceride; PL-AA, dietary arachidonic acid provided as phospholipid; LCP, long-chain polyunsaturated fatty acids; RPE, retinal pigment epithelium; CS, cesarean section; dGa, days of gestational age; FAME, fatty acid methyl esters; GC-FID, gas chromatography with flame ionization detector; GCC-IRMS, gas chromatography–combustion isotope ratio mass spectrometry
机译:花生四烯酸(AA)是一种在人母乳中以甘油三酸酯(TG)和磷脂(PL)形式存在的长链多不饱和酸酯(LCP)。婴儿配方食品中,AA脂质形式的代谢后果鲜有关注。我们的目标是研究饮食性TG和PL作为AA携带者,这些狒狒通过食用具有人乳中典型LCP成分的配方的足月狒狒新生儿在大脑和相关器官中增生。 TG和磷脂酰胆碱(PC)在sn-2位置具有[U-13C] -AA,在其余位置(分别为TG-AA *或PL-AA *)具有未标记的16:0作为示踪剂,研究了组织AA *掺入。狒狒新生儿在生命的18至19天接受一次口服TG-AA *(n = 3)或PL-AA *(n = 4)口服。 10 d后(生命28-29 d)获得组织,并测量同位素富集。在大脑中,分别将4.5%的PL-AA *剂量和2.1%的TG-AA *剂量回收为大脑AA *,这表明PL的底物效力比TG的2.1倍高大脑AA积聚。在肝,肺,血浆和红细胞中也观察到PL衍生的AA *优先于TG *的AA *掺入。由于配方奶粉中TG-AA的数量优势,TG-AA的总脑AA积(以绝对重量表示)比PL-AA高5.0倍。我们估计,在足月狒狒新生儿中,大约一半的产后大脑AA增生来自膳食预制的AA,其食用配方的脂质成分与人乳相似。 AA *,[13C]花生四烯酸; DHA,二十二碳六烯酸; LA,亚油酸; TG,甘油三酸酯; PL,磷脂; PC,磷脂酰胆碱; TG-AA *,甘油三酸酯,在sn-2位含有[13C]花生四烯酸; PL-AA *,磷脂酰胆碱在sn-2位置含有[13C]花生四烯酸; TG-AA,膳食花生四烯酸,以甘油三酸酯形式提供; PL-AA,膳食花生四烯酸,以磷脂形式提供; LCP,长链多不饱和脂肪酸; RPE,视网膜色素上皮; CS,剖宫产; dGa,胎龄天数; FAME,脂肪酸甲酯; GC-FID,带火焰离子检测器的气相色谱仪; GCC-IRMS,气相色谱-燃烧同位素比质谱

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号